Neurovascular disorder
MONDO:0043218A disorder of the nervous system related to a vascular etiology.
Also known as: disease of nervous system vasculature, nervous system disorder of vasculature, neurovascular disorder, vasculature nervous system disorder
4209 clinical trials for this condition and its sub-types, 5 tagged with Neurovascular disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neurovascular disorder
-
Cerebrovascular disorder 108 trials · 3,292 incl. sub-types
24 sub-types
- Stroke disorder 2,037 trials · 2,854 incl. sub-types Sub-types →
- Brain ischemia 55 trials · 283 incl. sub-types Sub-types →
- Intracranial arterial disease 26 trials · 206 incl. sub-types Sub-types →
- Brain infarction 26 trials · 151 incl. sub-types Sub-types →
- Carotid artery disorder 41 trials · 114 incl. sub-types Sub-types →
- Vascular dementia 72 trials Sub-types →
- Cerebral artery stenosis 23 trials · 71 incl. sub-types Sub-types →
- Occlusion precerebral artery 0 trials · 25 incl. sub-types Sub-types →
- Pseudotumor cerebri 22 trials
- Cerebral amyloid angiopathy 16 trials · 17 incl. sub-types Sub-types →
- Cerebral sinovenous thrombosis 16 trials
- Intracranial thrombosis 12 trials · 13 incl. sub-types Sub-types →
- Intracranial vasospasm 13 trials
- APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types Sub-types →
- Basal ganglia cerebrovascular disorder 5 trials
- Internal carotid artery stenosis 5 trials
- Familial porencephaly 0 trials · 3 incl. sub-types Sub-types →
- Vascular brain injury 3 trials
- HTRA1-related autosomal dominant cerebral small vessel disease 2 trials
- Subclavian steal syndrome 1 trial
- Cathepsin a-related arteriopathy-strokes-leukoencephalopathy 0 trials
- Cerebral arteritis 0 trials
- Microangiopathy and leukoencephalopathy, pontine, autosomal dominant 0 trials
- Precerebral artery stenosis 0 trials
-
Migraine disorder 393 trials · 414 incl. sub-types
2 sub-types
- Migraine with aura 30 trials · 44 incl. sub-types Sub-types →
- Migraine without aura 42 trials
-
Retinal vascular disorder 9 trials · 324 incl. sub-types
12 sub-types
- Diabetic retinopathy 148 trials · 260 incl. sub-types Sub-types →
- Retinal vascular occlusion 0 trials · 53 incl. sub-types Sub-types →
- Exudative vitreoretinopathy 1 trial · 35 incl. sub-types Sub-types →
- Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations 3 trials
- Retinal telangiectasia 0 trials · 2 incl. sub-types Sub-types →
- Retinal vasculitis 2 trials
- Retinal hemangioblastoma 1 trial Sub-types →
- Retinal microaneurysm 1 trial
- Arteriosclerotic retinopathy 0 trials
- Familial retinal arterial macroaneurysm 0 trials
- Perifoveal exudative vascular anomalous complex 0 trials
- Vasoproliferative tumor of retina 0 trials
-
Intracranial hypertension 51 trials · 97 incl. sub-types
2 sub-types
- Hypertensive encephalopathy 1 trial · 28 incl. sub-types Sub-types →
- Pseudotumor cerebri 22 trials
-
Central nervous system vasculitis 3 trials · 55 incl. sub-types
5 sub-types
- Temporal arteritis 52 trials Sub-types →
- Primary central nervous system vasculitis 2 trials Sub-types →
- Benign angiitis of the central nervous system 0 trials
- Central nervous system AIDS arteritis 0 trials
- Cerebral arteritis 0 trials
-
Trigeminal autonomic cephalalgia 8 trials · 27 incl. sub-types
4 sub-types
- Cluster headache syndrome 26 trials Sub-types →
- Hemicrania continua 5 trials
- Paroxysmal Hemicrania 5 trials
- SUNCT syndrome 4 trials
-
Choroid plexus cancer 0 trials · 11 incl. sub-types
2 sub-types
- Choroid plexus carcinoma 11 trials Sub-types →
- Choroid plexus meningioma 0 trials
-
Hemangioblastoma 9 trials · 10 incl. sub-types
3 sub-types
- Retinal hemangioblastoma 1 trial Sub-types →
- Brain stem hemangioblastoma 0 trials
- Cerebellar hemangioblastoma 0 trials
-
Choroid cancer 0 trials · 10 incl. sub-types
1 sub-type
- Malignant choroid melanoma 10 trials Sub-types →
-
Lymphatic malformation 5 8 trials
-
Choroideremia 6 trials
2 sub-types
- Choroideremia hypopituitarism 0 trials
- Total central choroidal atrophy 0 trials
-
Cavernous sinus meningioma 2 trials
-
Benign choroid plexus neoplasm 0 trials · 2 incl. sub-types
1 sub-type
- Choroid plexus papilloma 2 trials
-
Central nervous system hemangioma 0 trials · 2 incl. sub-types
2 sub-types
- Intracranial hemangioma 0 trials · 2 incl. sub-types Sub-types →
- Hemangioma of peripheral nerve 0 trials
-
Retinal ischemia 1 trial
-
Hemangioma of retina 0 trials · 1 incl. sub-types
2 sub-types
- Retinal hemangioblastoma 1 trial Sub-types →
- Cavernous hemangioma of retina 0 trials
-
Norman-Roberts syndrome 0 trials
-
Wyburn-Mason syndrome 0 trials
-
Benign neoplasm of choroid 0 trials
2 sub-types
- Choroidal osteoma 0 trials
- Hemangioma of choroid 0 trials
-
Central nervous system angiosarcoma 0 trials
-
Choroidal sclerosis 0 trials
4 sub-types
- Angioid streaks of choroid 0 trials
- Diffuse secondary choroid atrophy 0 trials
- Hereditary choroidal atrophy 0 trials Sub-types →
- Senile atrophy of choroid 0 trials
-
Eyelid capillary hemangioma 0 trials
-
Neoplasm of aortic body 0 trials
-
1 sub-type
- Basal laminar drusen 0 trials
Most studied deeper sub-types
-
Tiny doses of avastin tested against laser for preemie eye disease
Disease control Stopped earlyThis study tested a low dose of the drug bevacizumab (Avastin) against standard laser treatment for retinopathy of prematurity, an eye disease that can blind premature infants. Sixteen babies with severe disease were enrolled. The goal was to see if the drug could control the dis…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a common vitamin speed stroke recovery?
Disease control Stopped earlyThis phase 2 trial tests whether extended-release niacin, a form of vitamin B3, can safely help people recover after an ischemic stroke. Researchers will give participants either niacin or a placebo daily, starting within a week of their stroke. The study tracks safety and measur…
Phase 2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New hope for stroke prevention: device offers alternative to blood thinners for heart patients
Disease control Stopped earlyThis study tested the WATCHMAN device, a small implant that closes off a part of the heart where clots often form, in 481 people with atrial fibrillation who cannot take blood thinners. The goal was to see if the device is safe and effective at reducing stroke risk. Participants …
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can light therapy dry out a swollen retina?
Disease control Stopped earlyThis pilot study tests whether shining near-infrared light on the eye can reduce macular edema—swelling in the central retina—caused by a retinal vein occlusion. Six participants with this condition will receive 12 light treatments over about five weeks. The main goal is to see i…
Sponsor: University of Sydney • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a single stem cell infusion rewire the brain after stroke?
Disease control Stopped earlyThis phase 3 trial is testing whether a single infusion of MultiStem, an experimental stem cell product, can improve recovery in adults who have had a moderate-to-severe ischemic stroke within the past 18 to 36 hours. The study compares the stem cell treatment against a placebo t…
Phase 3 • Sponsor: Healios K.K. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Remote care may cut stroke risk — a small trial puts it to the test
Disease control Stopped earlyThis trial tests whether a 6-month telehealth program can reduce stroke risk factors, especially high blood pressure, in people already at elevated risk. Participants receive personalized remote care including blood pressure monitoring, wearable tracking, and virtual visits with …
Sponsor: Syntrillo, Inc • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Experimental stroke drug takes first step in human safety trial
Disease control Stopped earlyThis trial tests the safety of a single intravenous dose of an experimental drug called NTS-104 tris in healthy adults aged 18 to 65. The drug is being developed as a potential treatment for acute ischemic stroke. Researchers will monitor participants for side effects and measure…
Phase 1 • Sponsor: NeuroTrauma Sciences, LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
5-Year Check-In on artery stenting for stroke prevention
Disease control Stopped earlyThis study follows 197 people who previously had a procedure called TCAR to treat carotid artery disease. Researchers will check for strokes, deaths, and whether the artery narrows again over 2 to 5 years. The goal is to see how well the treatment holds up over time.
Sponsor: Silk Road Medical • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Stroke drug study halted early: new dosing regimen tested in 17 patients
Disease control Stopped earlyThis study aimed to find the best dose of MCI-186 for people who had an acute ischemic stroke. It compared a new way of giving the drug (a bolus followed by continuous infusion) with the standard twice-daily dosing for 14 days. The trial was terminated early and included only 17 …
Phase 2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Cooling blankets tested to save newborn brains after oxygen loss
Disease control Stopped earlyThis study tested four different cooling treatments for newborns who suffered brain injury from lack of oxygen at birth. The treatments varied in how low the body temperature was lowered (33.5°C or 32.0°C) and how long cooling lasted (72 or 120 hours). The goal was to see which a…
Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New proton therapy aims to save eyes from removal in large melanoma cases
Disease control Stopped earlyThis study tested two different proton therapy schedules for people with large choroidal melanomas (eye cancer) that would normally require removal of the eye. The goal was to see if a gentler radiation schedule could control the tumor and avoid severe side effects, allowing pati…
Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a blood pressure cuff boost stroke recovery? trial tests the idea
Disease control Stopped earlyThis study tested whether repeatedly inflating and deflating a blood pressure cuff on the arm (remote ischemic conditioning) could improve recovery in 458 people who had a severe stroke caused by a blocked artery in the brain. The goal was to see if this simple, non-drug treatmen…
Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental Artery-Directed chemo for rare brain tumors: tiny trial ends early
Disease control Stopped earlyThis early-phase trial tested giving chemotherapy drugs directly into the brain's arteries to treat two rare types of choroid plexus tumors. The goal was to shrink the tumor before a second surgery. Only 1 person was enrolled, and the study was terminated, so we have very little …
Phase 1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Brain bleed study halted: sodium Lactate's promise unproven
Disease control Stopped earlyThis study aimed to see if sodium lactate could improve blood flow in the brain after a severe type of stroke called subarachnoid hemorrhage. Only 3 patients were enrolled before the study was stopped early. The goal was to measure changes in brain blood flow using a special scan…
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Botulinum injection trial for arm spasticity halted early
Disease control Stopped earlyThis study tested whether injections of MYOBLOC (botulinum toxin type B) can safely reduce muscle tightness in the arm and hand of adults with spasticity caused by stroke, brain injury, multiple sclerosis, or other conditions. The trial planned to enroll about 300 participants bu…
Phase 2/3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Eye stroke treatment put to the test: can clot busters save sight?
Disease control Stopped earlyThis study tested whether giving a clot-busting drug (tenecteplase or alteplase) within 4.5 hours of an eye stroke could restore vision. Eye stroke, or central retinal artery occlusion, is a blockage in the eye's main artery that often causes permanent vision loss. The trial aime…
Phase 3 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Eye injection study for diabetes-related vision loss ends early
Disease control Stopped earlyThis study tested a single injection of avoralstat into the eye for people with diabetic macular edema, a condition that causes vision loss in diabetes. Only 3 adults took part before the study was stopped early. The main goal was to check safety and see if the drug might help re…
Phase 1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Statin study halted early: did high doses shield the brain during surgery?
Disease control Stopped earlyThis study looked at whether taking high doses of statins for two weeks before carotid artery surgery could prevent memory and thinking problems after the operation. It included 31 adults with severe carotid artery narrowing. The study was stopped early, so the results are limite…
Phase 3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Brain bleed drug combo study halted after just one patient
Disease control Stopped earlyThis study looked at whether adding the drug pioglitazone to a keyhole brain surgery (MIPS) could help people recover from a severe bleeding stroke. Only one person took part before the study was stopped early. The goal was to see if the combination was safe and helped clear the …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New stroke device trial halted early – too soon to tell
Disease control Stopped earlyThis study tested a new device called Envi™-SR for removing blood clots in people having a severe ischemic stroke. The goal was to see if it works as well as devices already approved by the FDA. However, the trial was stopped early after enrolling only 12 people, so we don't have…
Sponsor: NeuroVasc Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New steerable wire aims to simplify brain aneurysm repair
Disease control Stopped earlyThis study tested a new steerable guidewire called SmartGUIDE for treating unruptured brain aneurysms. The wire has a bendable tip that doctors can control during the procedure, potentially making it easier to reach the aneurysm. Only 5 people took part before the study was stopp…
Sponsor: Artiria Medical • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Stroke patients taken directly to treatment may recover better
Disease control Stopped earlyThis study tested whether taking people with severe stroke symptoms directly to the angio-suite for clot removal, instead of first doing a CT or MRI scan, leads to better recovery at 3 months. About 120 adults aged 18-85 with severe stroke were randomly assigned to either direct …
Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Brain bleed drug trial halted early – what we know
Disease control Stopped earlyThis study tested a drug called edaravone dexborneol (Sanbexin IV) in 80 people who had a brain bleed (intracerebral hemorrhage). The goal was to see if it is safe and helps recovery when added to standard care. The trial was stopped early, so the results are limited and more res…
Phase 2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Experimental DME pill trial ends early after just one patient
Disease control Stopped earlyThis early-stage study tested a new oral drug called K9 for diabetic macular edema, a condition that causes vision loss in people with diabetes. The trial was stopped early and only enrolled one person. The main goal was to check safety and measure changes in retinal swelling and…
Phase 1 • Sponsor: Michelle Abou-Jaoude • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could an arthritis drug tame giant cell arteritis?
Disease control Stopped earlyThis study tested whether adding anakinra, an anti-inflammatory drug, to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a blood vessel disease. The trial planned to include 70 adults over 50 but was stopped early with only 30 participant…
Phase 3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Weekly Finger-Prick test may keep elderly patients safer on blood thinners
Disease control Stopped earlyThis study tested whether checking blood clotting levels every week with a small finger-prick device is better than the usual monthly lab test for elderly nursing home residents on blood thinners. The goal was to see which method keeps patients in the safe therapeutic range longe…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Migraine drug ajovy put to the test for better sleep
Disease control Stopped earlyThis study looked at whether fremanezumab (Ajovy), an FDA-approved monthly injection for migraine prevention, could also improve sleep in people with migraines. Researchers planned to track 22 participants over 4 months, comparing their migraine days and sleep quality before and …
Phase 4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Brain aneurysm device study halted early
Disease control Stopped earlyThis study looked at a device called the Pipeline Flex Embolization Device with Shield Technology to treat ruptured brain aneurysms that are hard to fix with surgery or coils. The goal was to see if it could safely block the aneurysm and prevent rebleeding. The study was stopped …
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control Stopped earlyThis early-stage trial tested a modified virus (VSV-IFNbetaTYRP1) in 12 patients with advanced melanoma that had spread or could not be removed by surgery. The virus was designed to infect and kill melanoma cells while also boosting the immune system's attack. The main goals were…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Stroke drug trial halted after just two patients
Disease control Stopped earlyThis study aimed to see if the antibiotic minocycline could improve outcomes after a stroke. Participants were to receive either standard care plus minocycline pills for five days, or standard care alone. However, the trial was stopped early after enrolling only 2 people, so no m…
Phase 2/3 • Sponsor: Maimonides Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Smartphone app aims to prevent second strokes in high-risk patients
Disease control Stopped earlyThis study tested a smartphone-based program to help stroke survivors with high blood pressure lower their risk of another stroke. The program involved tracking blood pressure and getting tailored reminders. The study was terminated early, so results are limited.
Sponsor: Northern California Institute of Research and Education • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Eye injections tested to save sight in rare coats disease
Disease control Stopped earlyThis study tested whether anti-VEGF injections into the eye could help treat Coats disease, a rare condition that causes abnormal blood vessels and fluid buildup in the retina, potentially leading to blindness. The trial included 18 people with early-stage Coats disease who had n…
Phase 3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Clot-Removal procedure for severe strokes put to the test
Disease control Stopped earlyThis study looked at whether a procedure to remove large blood clots from the brain could help people who had a severe stroke. It included 335 adults with a large stroke who could be treated within 7 hours. The goal was to see if the procedure reduced disability compared to stand…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Lithium shield: could a mood drug guard the brain during neck surgery?
Disease control Stopped earlyThis study tested whether giving lithium carbonate before carotid artery surgery could reduce brain damage and confusion after the operation. The trial planned to include 107 adults undergoing elective carotid surgery, but it was terminated early. The goal was to see if lithium c…
Phase 3 • Sponsor: Negovsky Reanimatology Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI takes on brain scans: could it match the experts?
Diagnosis Stopped earlyThis study will check if an artificial intelligence (AI) tool can help less experienced doctors read MRI scans of stroke patients as accurately as a brain scan specialist. About 500 adults who are being evaluated for a stroke will have their MRI results compared. The goal is to s…
Sponsor: Aarhus University Hospital • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
AI reads eye photos to spot Diabetes-Related vision loss
Diagnosis Stopped earlyThis study tests whether an artificial intelligence program called NeoRetina can accurately detect diabetic retinopathy and diabetic macular edema from simple eye photographs. Researchers will compare the AI's analysis to standard exams by eye doctors. The goal is to see if this …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New scan aims to spot brain bleeding after stroke – but study stalls
Diagnosis Stopped earlyThis study tested whether a cone beam CT scan, done right after a stroke procedure called thrombectomy, could tell the difference between a brain hemorrhage and harmless contrast dye buildup. Only 5 adults were enrolled before the study was stopped early. The goal was to see if t…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New PET tracer aims to reveal hidden immune activity in tumors and arteries
Diagnosis Stopped earlyThis Phase II study tested a radioactive tracer called 68GaNOTA-Anti-MMR-VHH2 to see if it can light up certain immune cells (macrophages) on PET scans. The trial included 29 people with head and neck cancer, lymphoma, atherosclerosis, or sarcoidosis. The goal was to see if the t…
Phase 2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New eye scanner software could sharpen diagnosis of macular degeneration
Diagnosis Stopped earlyThis study tested a new software called AngioScan, used with an already-approved eye camera, to see if it can take better pictures of the back of the eye. Researchers looked at 150 patients with retinal problems like macular degeneration. The goal was to find out if the software …
Sponsor: University of California, Los Angeles • Aim: Diagnosis
Last updated Jun 27, 2026 12:10 UTC
-
Neck-Worn swallow detector fails key test
Diagnosis Stopped earlyThis study tested a wearable device that sits on the neck to detect swallowing problems in people with conditions like stroke, Parkinson's, multiple sclerosis, Alzheimer's, or dementia. The device was compared to a standard X-ray test. Unfortunately, the device did not meet the a…
Sponsor: Société des Produits Nestlé (SPN) • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Gum treatment may slow memory loss in seniors
Prevention Stopped earlyThis study looked at whether intensive treatment for gum disease (periodontitis) could prevent dementia in older adults who already have mild cognitive impairment and narrowed neck arteries. Participants received either standard dental care or deep cleaning and root planing. The …
Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Migraine prevention drug trial in kids halted early
Prevention Stopped earlyThis study tested a drug called SPN-538 to prevent migraines in children aged 6 to 11. The trial was a randomized, double-blind, placebo-controlled study, meaning some children got the drug and some got a placebo. However, the study was terminated early and only enrolled 26 parti…
Phase 4 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
Can BOTOX shots stop migraines before they start? new study investigates
Prevention Stopped earlyThis study tested whether BOTOX injections can prevent migraine attacks in adults who have 6 to 14 migraine days per month (episodic migraine). About 775 participants received either BOTOX or placebo injections into their muscles twice, 12 weeks apart. The main goal was to see if…
Phase 3 • Sponsor: AbbVie • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Migraine drug trial for kids halted early – what we know
Symptom relief Stopped earlyThis study aimed to see if lasmiditan, a migraine medicine, is safe and works for children aged 6 to 17. It planned to treat migraine attacks and measure pain relief. The trial was stopped early, so final results are limited, but it may still provide useful information about trea…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Can gentle electrical pulses reawaken hand movement after stroke?
Symptom relief Stopped earlyThis trial tests different settings of a gentle electrical stimulation device, placed on the skin of the affected arm, to see which ones best improve hand function in people who have had a stroke. Participants will receive varying durations and strengths of stimulation, and resea…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Dementia agitation drug trial halted after just 5 patients
Symptom relief Stopped earlyThis study tested a fast-dissolving film (BXCL501) placed under the tongue to quickly reduce severe agitation in older adults with dementia. The trial aimed to enroll many participants but was stopped early after only 5 people joined. Because it ended so soon, we cannot draw reli…
Phase 2 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Nerve block or antidepressant? study tests two migraine treatments Head-to-Head
Symptom relief Stopped earlyThis study compares two treatments for transformed migraine (chronic daily headache): a sphenopalatine ganglion nerve block using lidocaine gel applied inside the nose, versus daily oral amitriptyline (Elavil), an antidepressant often used for migraine prevention. Ten adults aged…
Phase 4 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Multitasking rehab for stroke walkers: hype or help?
Symptom relief Stopped earlyThis study looked at whether practicing walking while doing other tasks (multitasking) helps people recovering from a stroke walk faster than just walking practice alone. It included 26 adults who had a stroke within the past 6 months and had trouble walking. The trial was stoppe…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Migraine drug for kids? trial cut short
Symptom relief Stopped earlyThis study tested the migraine drug lasmiditan in children aged 6 to 17 who have migraines. The goal was to see if it is safe and works for quick relief. The trial was stopped early, so the results are limited.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Heart hole closure for migraines? tiny study halted early
Symptom relief Stopped earlyThis study tested whether closing a small hole in the heart (called a PFO) with a device could reduce migraine headaches. It planned to compare the real procedure to a sham (fake) procedure in adults aged 18-55 with frequent migraines. However, the study was stopped early after e…
Sponsor: W.L.Gore & Associates • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Botox injections may help stroke survivors move their arms better
Symptom relief Stopped earlyThis study observed 18 chronic stroke patients who received botulinum toxin injections into their elbow muscles as part of routine care. The goal was to see if the injections reduced muscle tightness (spasticity) and improved active arm extension. Researchers measured muscle acti…
Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Botulinum toxin injection aimed at easing leg spasticity after stroke or injury
Symptom relief Stopped earlyThis study tested whether MYOBLOC, a botulinum toxin injection, can safely reduce muscle stiffness in the lower leg of adults with spasticity caused by stroke, brain injury, or spinal cord injury. About 40 participants received either a low or high dose of MYOBLOC or a placebo in…
Phase 2/3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New ankle brace aims to fix foot drop after stroke
Symptom relief Stopped earlyThis study tested a brace called CALIGALOC designed to correct foot drop (ankle varus) in people with hemiparesis after a stroke or other brain injury. The goal was to see if wearing the brace for 15 days improved walking speed and balance. Only 5 people took part, and the study …
Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Experimental drug aims to curb disinhibition in dementia patients
Symptom relief Stopped earlyThis study tested a drug called AVP-786 to see if it could safely reduce disinhibition—impulsive or inappropriate behavior—in people with neurodegenerative disorders like Alzheimer's or frontotemporal dementia. The trial planned to include many participants but was terminated ear…
Phase 2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Touchscreen device aims to give voice to dementia patients
Symptom relief Stopped earlyThis study tested a personalized touchscreen device (My PATI) to help people with Alzheimer's or related dementias communicate their care preferences. The goal was to improve quality of life for both patients and their caregivers. The study was terminated early, so results are li…
Sponsor: Florida International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Could a simple pill replace IVs for migraines in the ER?
Symptom relief Stopped earlyThis study looked at two FDA-approved migraine medications (a dissolving tablet and a nasal spray) given to adults in the emergency department. The goal was to see if these easy-to-use options could relieve pain quickly and shorten ER visits. The study was stopped early with only…
Phase 4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Can a brain ZAP boost stroke recovery? new pilot study explores
Symptom relief Stopped earlyThis small pilot study tested whether combining a gentle brain stimulation technique (tDCS) with a thinking-strategies training program could help people who had a stroke more than six months ago perform everyday activities better. Eleven participants were enrolled to see if the …
Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Vibration vest aims to restore arm function in stroke survivors
Symptom relief Stopped earlyThis study tested a wearable device that uses gentle vibrations to help stroke survivors improve arm strength and movement. The plan was to have 48 people use the device at home for 4 weeks, but only 4 enrolled before the study was stopped. Researchers measured usability and chan…
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Cortisone shot for Post-Stroke shoulder pain: did it help?
Symptom relief Stopped earlyThis study looked at whether a cortisone injection into the shoulder joint, combined with physiotherapy, reduces pain and improves movement in people who had a stroke and developed shoulder pain. It included 50 adults in a rehab program. The study was stopped early, so results ar…
Phase 4 • Sponsor: Claire Bourgeois • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New drug aimed at treating apathy in dementia patients tested
Symptom relief Stopped earlyThis study tested a drug called CVL-871 to see if it is safe and can help reduce apathy (lack of motivation or interest) in people with dementia. The trial included 41 participants with mild to moderate dementia and clinically significant apathy. The main goal was to check for si…
Phase 2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Brainwave training tested for aphasia recovery
Symptom relief Stopped earlyThis study tested whether EEG neurofeedback—a type of brain training that uses real-time brainwave readings—can help people with aphasia (trouble speaking or understanding language) improve their communication, sleep, and anxiety. Seven adults with aphasia from stroke or primary …
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Cooling the brain through the nose: new device tested for ICU fever
Symptom relief Stopped earlyThis study tested a device called CoolStat that is placed in the nose to cool down brain-injured patients with fever in the ICU. The goal was to see if it could safely and quickly bring their temperature to normal. Only 9 patients were enrolled before the study was stopped early,…
Sponsor: CoolTech LLC • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Needle-Free migraine relief for kids? nasal spray cocktail tested in ER
Symptom relief Stopped earlyThis study tested whether a nasal spray version of the migraine drug Ketorolac, combined with oral Prochlorperazine and Diphenhydramine, could relieve migraine pain in children as effectively as the standard IV treatment. The trial aimed to enroll children aged 4 and older with m…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Magnetic zaps to the brain aim to restore arm movement in stroke survivors
Symptom relief Stopped earlyThis study tested whether a magnetic device (rTMS) placed on the scalp could help people who had a stroke regain movement in their arm. The trial planned to include 60 adults with recent ischemic stroke. However, the study was terminated early, so the results are not complete.
Sponsor: Seoul National University Bundang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Robot-Assisted walking program shows promise for brain injury recovery
Symptom relief Stopped earlyThis study tested a personalized walking and balance training program using a KineAssist robotic treadmill for people recovering from traumatic brain injury, stroke, or other acquired brain injuries. The goal was to safely challenge and improve walking speed, balance, strength, a…
Sponsor: The University of Texas Medical Branch, Galveston • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Stroke arm rehab study halted early – no clear answers yet
Symptom relief Stopped earlyThis study looked at whether adding functional electrical stimulation (FES) to robotic hand therapy could improve arm movement in people who had a stroke within the past year. Researchers planned to compare two groups: one getting standard rehab plus robotic therapy and FES, and …
Sponsor: Neuron, Spain • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Migraine drug trial halted midway
Symptom relief Stopped earlyThis study tested an experimental drug called K-645 for people having a migraine attack. It aimed to see if the drug could stop pain and other bothersome symptoms better than a placebo. The trial was stopped early, so results are limited. About 134 adults with a history of migrai…
Phase 2 • Sponsor: Kallyope Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can gentle balance challenges help stroke survivors walk better?
Symptom relief Stopped earlyThis study tested whether adding safe balance challenges (called perturbations) to body-weight supported walking therapy helps stroke survivors improve their balance and walking more than standard therapy alone. Participants were adults in inpatient rehab after a stroke. They use…
Sponsor: Gaylord Hospital, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Can a smart armband take the sting out of migraine shots?
Symptom relief Stopped earlyThis study tested a wearable armband called Nerivio that uses mild electrical pulses to reduce pain from Botox injections in people with chronic migraine. About 80 participants were planned, but the study was stopped early. The goal was to see if the device could make the injecti…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Migraine showdown: which pill stops the pain faster?
Symptom relief Stopped earlyThis study looked at whether a common painkiller (diclofenac potassium) works as well as a newer migraine drug (rimegepant) for stopping migraine pain within 2 hours. About 300 adults with migraine took one of the two medicines during a single attack. The goal was to see if both …
Phase 4 • Sponsor: Danish Headache Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Stroke rehab boost: exercise plus Self-Management may keep patients moving
Symptom relief Stopped earlyThis study tested a program called PROPEL that combines group aerobic exercise with weekly self-management discussions for people recovering from a stroke. The goal was to see if this approach helps participants stay physically active for six months after leaving rehabilitation. …
Sponsor: Toronto Rehabilitation Institute • Aim: Symptom relief
Last updated Jun 26, 2026 17:34 UTC
-
Migraine device trial halted early – what we know
Symptom relief Stopped earlyThis study followed 98 people with chronic migraine who used a device that delivers gentle oscillations inside the nose. The goal was to see if regular use could cut down on severe headache days. The trial was terminated early, so the full results are not available, but the appro…
Sponsor: Chordate Medical • Aim: Symptom relief
Last updated Jun 26, 2026 15:29 UTC
-
New exercise approach may boost fitness and balance in stroke survivors
Symptom relief Stopped earlyThis study tested whether reactive balance training—exercises that involve sudden pushes, pulls, or quick movements—can improve aerobic fitness and leg strength in people who had a stroke at least six months ago. The researchers expected that this training would be as good as sta…
Sponsor: Toronto Rehabilitation Institute • Aim: Symptom relief
Last updated Jun 26, 2026 15:24 UTC
-
Migraine ER drug trial halted early – no clear results
Symptom relief Stopped earlyThis study tested whether adding clorazepate (a sedative) to standard migraine medications could provide faster pain relief for people having a migraine attack in the emergency room. The trial included 323 adults with moderate to severe migraine. However, the study was terminated…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 26, 2026 14:44 UTC
-
Zap to talk: brain stimulation tried for aphasia after stroke
Symptom relief Stopped earlyThis study tested whether a gentle electrical current applied to the scalp (tDCS) during speech therapy could help stroke survivors with aphasia name objects better. Only 5 people took part, and the study was stopped early, so the results are not reliable enough to draw conclusio…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Jun 26, 2026 13:31 UTC
-
Can PET scans reveal hidden heart inflammation after a stroke?
Knowledge-focused Stopped earlyPeople who have a stroke face a much higher risk of heart problems in the following weeks, but researchers do not fully understand why. This study uses PET/MRI scans of the heart and blood tests for inflammatory markers to see whether inflammation develops in the heart after a st…
Sponsor: Luciano A. Sposato • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Robots map how brain and nerve injuries disrupt everyday arm tasks
Knowledge-focused Stopped earlyResearchers at the University of Pennsylvania are studying how people with stroke, upper limb amputation, spinal cord injury, or cerebral palsy move their arms during common daily activities like drinking and pouring. The study uses two passive desktop robots to track the motion …
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New tool could help stroke survivors regain social connection
Knowledge-focused Stopped earlyThis study aims to create a tool to assess how well people understand tone of voice (prosody) after a right-sided stroke. Over half of right-stroke patients have trouble with prosody, which can affect social interactions and quality of life. Researchers will test 150 participants…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
New PET tracer could spot dangerous plaques before they cause strokes
Knowledge-focused Stopped earlyThis study compares a new imaging tracer, 68Ga-NODAGA-RGD, with standard methods (FDG-PET, MRI, ultrasound) to detect inflamed plaques in the carotid arteries. Twenty people scheduled for plaque-removal surgery will receive the tracer and undergo scans. The goal is to see which t…
Phase 1/2 • Sponsor: University of Lausanne Hospitals • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Psychedelics rewire Brain's learning? yale study investigates
Knowledge-focused Stopped earlyThis observational study at Yale University is recruiting 200 people who are already taking part in another trial where they may receive a serotonergic psychedelic (like psilocybin or LSD) or a placebo. Researchers want to understand how these substances change the brain's inform…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Hidden heart rhythm disorder may be behind many unexplained strokes
Knowledge-focused Stopped earlyThis study looks at people who had a stroke or mini-stroke with no known cause (cryptogenic stroke). Researchers want to see if a small device implanted under the skin, called an implantable loop recorder, can detect hidden atrial fibrillation — an irregular heart rhythm that can…
Sponsor: University of Valencia • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Real-World data on brain aneurysm device could improve patient safety
Knowledge-focused Stopped earlyThis study observes people who have already been treated with the Pipeline Embolization Device for brain aneurysms. Researchers track neurological complications like stroke or bleeding to better understand the device's safety in everyday use. The goal is to expand knowledge on ho…
Sponsor: Medtronic Neurovascular Clinical Affairs • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Stroke study seeks brain regions to boost arm healing
Knowledge-focused Stopped earlyThis study aimed to identify brain areas outside the main motor region that help arm recovery after a severe stroke. Researchers followed 28 patients over time, using MRI and movement tracking to see which brain areas became active as arm function improved. The goal was to find n…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Tiny implant zaps nerves to boost stroke rehab
Knowledge-focused Stopped earlyThis study tested whether a small implanted device that stimulates the vagus nerve could improve arm and hand function in people who had a stroke at least a year ago. Four participants received either real or sham stimulation paired with physical therapy. The goal was to see how …
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Brain injury and ARDS: which breathing maneuver is safer?
Knowledge-focused Stopped earlyThis study compared two breathing techniques (CPAP and eSigh) in 18 patients with brain injury and acute respiratory distress syndrome (ARDS). The goal was to see which method better maintains oxygen levels in the brain without causing harm. The trial was terminated early, so fin…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Stroke's hidden toll: brain scans reveal emotion perception changes
Knowledge-focused Stopped earlyThis study looked at how stroke changes the brain's ability to recognize emotions like fear and happiness. Researchers used MRI and EEG to compare stroke patients with healthy volunteers. The study was stopped early and only included 2 participants, so findings are very limited.
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Brain zaps tested for stroke arm recovery – but study stalls
Knowledge-focused Stopped earlyThis study tested whether a single session of magnetic brain stimulation (called rTMS) over a specific brain area could improve pointing movements in people who had a stroke. Only one person took part, and the study was stopped early. The goal was to see if the stimulation could …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New ICU cockpit software aims to predict brain complications before they happen
Knowledge-focused Stopped earlyThis study tested a software platform called ICU Cockpit that collects and displays vital signs and other data from brain-injury patients in the intensive care unit. The goal was to help doctors make faster, better decisions and to predict complications like strokes or unstable c…
Sponsor: Emanuela Keller • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Mental health study aims to uncover Long-Term heart risks
Knowledge-focused Stopped earlyThis study followed 167 adults with mental health issues like anxiety, depression, or sleep problems who visited their primary care doctor. Researchers used health conversations and a blood test to track lifestyle changes and heart disease risks over up to 20 years. The goal was …
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Blood test may predict stroke after carotid surgery
Knowledge-focused Stopped earlyThis study aimed to see if a blood test measuring platelet function could predict neurological events like stroke in people undergoing carotid artery surgery. Researchers planned to enroll 650 patients but the study was terminated early. The test uses a device called Multiplate t…
Sponsor: Scientific Institute San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Eye test may forecast kidney failure after cancer surgery
Knowledge-focused Stopped earlyThis study looked at whether special eye scans (OCT-angiography) can predict how well the remaining kidney will work one year after kidney removal for cancer. Researchers enrolled 30 adults scheduled for total nephrectomy. The goal was to see if retinal blood vessel patterns coul…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Spinal tap could replace brain surgery for young tumor patients
Knowledge-focused Stopped earlyThis study looked at whether a liquid biopsy—testing the fluid around the brain and spinal cord—can find tumor DNA in children and young adults with brain tumors. The goal was to see if this safer, non-surgical test could replace risky tissue biopsies for diagnosis and monitoring…
Sponsor: Pediatric Brain Tumor Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New eye camera could spot hidden signs of blindness
Knowledge-focused Stopped earlyThis study tested a new, non-invasive eye imaging method called hyperspectral imaging. It takes pictures of the back of the eye using many different colors of light to find details not visible with standard cameras. About 679 adults with healthy eyes or eye diseases like diabetic…
Sponsor: Center for Eye Research Australia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Nurse phone calls may boost headache treatment success
Knowledge-focused Stopped earlyThis study looked at whether follow-up calls from a headache nurse could help patients with migraines, tension headaches, cluster headaches, or hemicrania continua stay on their preventive medication. 147 participants were randomly assigned to receive nurse calls at 2 and 6 weeks…
Sponsor: Norwegian University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New tech aims to make emergency brain drains safer and more accurate
Knowledge-focused Stopped earlyThis study tested whether using a special image-guidance system (AxiEM Stealth) helps doctors place a brain drain more accurately at the bedside compared to the usual freehand method. The drain is needed to relieve pressure in the brain. The study included 31 adults who needed th…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Spinal zap fails to prove brain benefit in rare stroke complication
Knowledge-focused Stopped earlyThis study looked at whether electrical stimulation of the spinal cord could help widen narrowed brain arteries after a type of stroke called subarachnoid hemorrhage. Only one person was enrolled before the study was stopped early. The goal was to measure changes in blood flow, b…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New monitoring technique for vascular surgery falls short
Knowledge-focused Stopped earlyThis study looked at whether adding a special imaging test (Cytocam-IDF) to standard monitoring during major vascular surgery could help patients leave the hospital sooner. The trial was planned for more participants but was stopped early after only 22 people took part. Because i…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Tiny study explores why stroke survivors struggle to walk
Knowledge-focused Stopped earlyThis observational study aimed to understand how stroke affects walking during early recovery. Researchers used motion analysis and brain stimulation to track changes in 6 participants over 6 months. The study was terminated early, so findings are limited.
Sponsor: Danderyd Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Small study measures rapid muscle decline after stroke
Knowledge-focused Stopped earlyThis study aimed to monitor muscle strength and body composition changes in the first 10 days after a severe stroke. Researchers used a device called an impedancemeter to measure muscle mass and a dynamometer to test grip strength. Only 6 people participated before the study was …
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Could a simple switch in catheters prevent post-stroke delirium?
Knowledge-focused Stopped earlyThis study looked at whether using a condom catheter instead of a standard indwelling urinary catheter (IUC) lowers the chance of delirium in men aged 70+ who had a stroke. Delirium is a sudden confused state that can happen after a stroke. The trial planned to compare two groups…
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Family involvement in stroke rehab shows promise but study cut short
Knowledge-focused Stopped earlyThis study looked at whether having a family member work closely with hospital staff could improve recovery for stroke survivors with spatial neglect—a condition where people ignore one side of their world. The study planned to include more people but was stopped early, so only 1…
Sponsor: Kessler Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New tool aims to measure brain injury recovery confidence
Knowledge-focused Stopped earlyThis study tested a new questionnaire called the Brain Injury Self-Efficacy Scale to see how well it measures a person's confidence in managing challenges after a brain injury. Researchers compared it with other standard self-efficacy scales. The study involved 150 adults with a …
Sponsor: Rehabilitation Hospital of Indiana • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Migraine drug satisfaction study ends early – what did we learn?
Knowledge-focused Stopped earlyThis study followed 37 migraine patients in the Gulf region who had just started taking erenumab. Researchers measured how satisfied patients were with the treatment over 12 weeks using a questionnaire. The study was observational, meaning patients received their normal care, and…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Tiny study probes how seizure meds affect brain wiring after injury
Knowledge-focused Stopped earlyThis pilot study aimed to see if antiseizure drugs like phenobarbital and levetiracetam change brain connectivity patterns in people with severe acute brain injury and reduced consciousness. Only 5 participants were enrolled before the study was terminated. Researchers used resti…
Phase 4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Scientists examine stored tumor samples to uncover DNA clues in Kids' brain cancers
Knowledge-focused Stopped earlyThis study looked at stored tumor samples from 139 children with brain and central nervous system tumors. Researchers wanted to find DNA changes and biomarkers that could help understand these cancers better. The study was terminated early, so results may be limited.
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Sedative showdown in TBI: propofol vs midazolam study halted after just one patient
Knowledge-focused Stopped earlyThis study aimed to compare two common sedatives, propofol and midazolam, in patients with traumatic brain injury who needed a breathing tube. Researchers wanted to see if one drug led to better recovery or different levels of inflammation markers called cytokines. However, the t…
Phase 4 • Sponsor: Michigan State University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:20 UTC